Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.170
-0.020 (-0.91%)
At close: Apr 17, 2026, 4:00 PM EDT
2.150
-0.020 (-0.92%)
After-hours: Apr 17, 2026, 7:59 PM EDT
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$657,313
Market Cap
179.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 479 | 148 | 44.71% |
| Mar 31, 2024 | 331 | 47 | 16.55% |
| Mar 31, 2023 | 284 | 78 | 37.86% |
| Mar 31, 2022 | 206 | 54 | 35.53% |
| Mar 31, 2021 | 152 | 30 | 24.59% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsREPL News
- 6 days ago - FDA Rejection Sparks Questions On Replimune Drug Approval Path - Benzinga
- 9 days ago - Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma - GlobeNewsWire
- 9 days ago - US FDA declines to approve Replimune's drug for advanced skin cancer - Reuters
- 6 weeks ago - Replimune to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - The Short List — Top 10 Most Shorted Stocks Right Now - Benzinga
- 5 months ago - Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) - GlobeNewsWire